Global and China Bevacizumab Biosimilar Market Research Report Forecast 2017 to 2022

July 2017 | 116 pages | ID: G65CDE20FA7EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The Global and China Bevacizumab Biosimilar Market Research Report Forecast 2017-2022is a valuable source of insightful data for business strategists. It provides the Bevacizumab Biosimilar industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). This Bevacizumab Biosimilar market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global and China Bevacizumab Biosimilar Market: Regional Segment Analysis

Global
China

The Major players reported in the market include:

Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals

Global and China Bevacizumab Biosimilar Market:Product Segment Analysis

• Type 1
• Type 2
• Type 3

Global and China Bevacizumab Biosimilar Market:Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 BEVACIZUMAB BIOSIMILAR MARKET OVERVIEW

1.1 Bevacizumab Biosimilar Definition
1.2 Bevacizumab Biosimilar Classification
1.3 Bevacizumab Biosimilar Application
1.4 Bevacizumab Biosimilar Industry Overview
  1.4.1 Global Bevacizumab Biosimilar Sales and Growth Rate Forecast (2012-2022)
  1.4.2 China Bevacizumab Biosimilar Sales and Growth Rate Forecast (2012-2022)

CHAPTER 2 GLOBAL AND CHINA ECONOMIC IMPACT ON BEVACIZUMAB BIOSIMILAR INDUSTRY

2.1 Global Macroeconomic Environment Analysis
2.2 China Macroeconomic Environment Analysis

CHAPTER 3 GLOBAL BEVACIZUMAB BIOSIMILAR COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

3.1 Global Bevacizumab Biosimilar Market Competition by Manufacturers
  3.1.1 Global Bevacizumab Biosimilar Sales and Market Share of Key Manufacturers (2012-2017)
  3.1.2 Global Bevacizumab Biosimilar Revenue and Share by Manufacturers (2012-2017)
3.2 Global Bevacizumab Biosimilar Sales and Revenue by Type
  3.3.1 Global Bevacizumab Biosimilar Sales and Market Share by Type (2012-2017)
  3.3.2 Global Bevacizumab Biosimilar Revenue and Market Share by Type (2012-2017)
3.3 Global Bevacizumab Biosimilar Sales and Revenue by Application

CHAPTER 4 CHINA BEVACIZUMAB BIOSIMILAR MARKET ANALYSIS

4.1 China Bevacizumab Biosimilar Sales and Revenue (2012-2017)
  4.1.1 China Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
  4.1.2 China Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
  4.1.3 China Bevacizumab Biosimilar Sales Price Trend (2012-2017)
4.2 China Bevacizumab Biosimilar Sales and Market Share by Manufacturers
4.3 China Bevacizumab Biosimilar Sales and Market Share by Type
4.4 China Bevacizumab Biosimilar Sales and Market Share by Application

CHAPTER 5 GLOBAL BEVACIZUMAB BIOSIMILAR MANUFACTURERS ANALYSIS

5.1 Pfizer
  5.1.1 Company Profile
  5.1.2 Product Type, Application and Specification
  5.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.1.4 Business Overview
5.2 Allergan
  5.2.1 Company Profile
  5.2.2 Product Type, Application and Specification
  5.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.2.4 Business Overview
5.3 Alnylam Pharmaceuticals
  5.3.1 Company Profile
  5.3.2 Product Type, Application and Specification
  5.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.3.4 Business Overview
5.4 Amgen
  5.4.1 Company Profile
  5.4.2 Product Type, Application and Specification
  5.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.4.4 Business Overview
5.5 Angstrom Pharmaceuticals
  5.5.1 Company Profile
  5.5.2 Product Type, Application and Specification
  5.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.5.4 Business Overview
5.6 Acceleron Pharma
  5.6.1 Company Profile
  5.6.2 Product Type, Application and Specification
  5.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.6.4 Business Overview
5.7 Biocon
  5.7.1 Company Profile
  5.7.2 Product Type, Application and Specification
  5.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.7.4 Business Overview
5.8 Bionomics
  5.8.1 Company Profile
  5.8.2 Product Type, Application and Specification
  5.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.8.4 Business Overview
5.9 CASI Pharmaceuticals
  5.9.1 Company Profile
  5.9.2 Product Type, Application and Specification
  5.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  5.9.4 Business Overview

CHAPTER 6 BEVACIZUMAB BIOSIMILAR MANUFACTURING COST ANALYSIS

6.1 Bevacizumab Biosimilar Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.3 Manufacturing Process Analysis of Bevacizumab Biosimilar

CHAPTER 7 MARKET EFFECT FACTORS ANALYSIS

7.1 Technology Progress/Risk
  7.1.1 Substitutes Threat
  7.1.2 Technology Progress in Related Industry
7.2 Consumer Needs/Customer Preference Change
7.3 Economic/Political Environmental Change

CHAPTER 8 GLOBAL BEVACIZUMAB BIOSIMILAR MARKET FORECAST (2017-2022)

8.1 Global Bevacizumab Biosimilar Sales, Revenue Forecast (2017-2022)
8.2 Global Bevacizumab Biosimilar Sales Forecast by Type (2017-2022)
8.3 Global Bevacizumab Biosimilar Sales Forecast by Application (2017-2022)
8.4 Bevacizumab Biosimilar Price Forecast (2017-2022)

CHAPTER 9 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bevacizumab Biosimilar
Figure Global Sales Market Share of Bevacizumab Biosimilar by Type in 2016
Table Bevacizumab Biosimilar Sales Market Share by Application in 2016
Table Global Bevacizumab Biosimilar Sales of Key Manufacturers (2015 and 2016)
Table Global Bevacizumab Biosimilar Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bevacizumab Biosimilar Sales Share by Manufacturers
Figure 2016 Bevacizumab Biosimilar Sales Share by Manufacturers
Table Global Bevacizumab Biosimilar Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Bevacizumab Biosimilar Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Bevacizumab Biosimilar Revenue Share by Manufacturers
Table 2016 Global Bevacizumab Biosimilar Revenue Share by Manufacturers
Table Global Market Bevacizumab Biosimilar Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Bevacizumab Biosimilar Average Price of Key Manufacturers in 2016
Table Manufacturers Bevacizumab Biosimilar Manufacturing Base Distribution and Sales Area
Table Manufacturers Bevacizumab Biosimilar Product Type
Figure Bevacizumab Biosimilar Market Share of Top 3 Manufacturers
Figure Bevacizumab Biosimilar Market Share of Top 5 Manufacturers
Table Global Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Table China Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Table Global Bevacizumab Biosimilar Sales by Type (2012-2017)
Table Global Bevacizumab Biosimilar Sales Share by Type (2012-2017)
Figure Sales Market Share of Bevacizumab Biosimilar by Type (2012-2017)
Figure 2015 Sales Market Share of Bevacizumab Biosimilar by Type
Table Global Bevacizumab Biosimilar Revenue by Type (2012-2017)
Table Global Bevacizumab Biosimilar Revenue Share by Type (2012-2017)
Figure Sales Revenue Share of Bevacizumab Biosimilar by Type (2012-2017)
Figure 2015 Revenue Market Share of Bevacizumab Biosimilar by Type
Table Global Bevacizumab Biosimilar Price by Type (2012-2017)
Figure Global Bevacizumab Biosimilar Sales Growth by Type (2012-2017)
Table Global Bevacizumab Biosimilar Sales by Application (2012-2017)
Table Global Bevacizumab Biosimilar Sales Market Share by Application (2012-2017)
Figure Global Bevacizumab Biosimilar Sales Market Share by Application in 2016
Table Global Bevacizumab Biosimilar Sales Growth Rate by Application (2012-2017)
Figure Global Bevacizumab Biosimilar Sales Growth Rate by Application (2012-2017)
Figure China Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
Figure China Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
Figure China Bevacizumab Biosimilar Sales Price Trend (2012-2017)
Table China Bevacizumab Biosimilar Sales by Manufacturers (2012-2017)
Table China Bevacizumab Biosimilar Market Share by Manufacturers (2012-2017)
Table China Bevacizumab Biosimilar Sales by Type (2012-2017)
Table China Bevacizumab Biosimilar Market Share by Type (2012-2017)
Table China Bevacizumab Biosimilar Sales by Application (2012-2017)
Table China Bevacizumab Biosimilar Market Share by Application (2012-2017)
Table Pfizer Profile
Table Pfizer Bevacizumab BiosimilarSales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Bevacizumab BiosimilarMarket Share (2012-2017)
Table Allergan Profile
Table Allergan Bevacizumab BiosimilarSales, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Bevacizumab BiosimilarMarket Share (2012-2017)
Table Alnylam Pharmaceuticals Profile
Table Alnylam Pharmaceuticals Bevacizumab BiosimilarSales, Revenue, Price and Gross Margin (2012-2017)
Table Alnylam Pharmaceuticals Bevacizumab BiosimilarMarket Share (2012-2017)
Table Amgen Profile
Table Amgen Bevacizumab BiosimilarSales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Bevacizumab BiosimilarMarket Share (2012-2017)
Table Angstrom Pharmaceuticals Profile
Table Angstrom Pharmaceuticals Bevacizumab BiosimilarSales, Revenue, Price and Gross Margin (2012-2017)
Table Angstrom Pharmaceuticals Bevacizumab BiosimilarMarket Share (2012-2017)
Table Acceleron Pharma Profile
Table Acceleron Pharma Bevacizumab BiosimilarSales, Revenue, Price and Gross Margin (2012-2017)
Table Acceleron Pharma Bevacizumab BiosimilarMarket Share (2012-2017)
Table Biocon Profile
Table Biocon Bevacizumab BiosimilarSales, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Bevacizumab BiosimilarMarket Share (2012-2017)
Table Bionomics Profile
Table Bionomics Bevacizumab BiosimilarSales, Revenue, Price and Gross Margin (2012-2017)
Table Bionomics Bevacizumab BiosimilarMarket Share (2012-2017)
Table CASI Pharmaceuticals Profile
Table CASI Pharmaceuticals Bevacizumab BiosimilarSales, Revenue, Price and Gross Margin (2012-2017)
Table CASI Pharmaceuticals Bevacizumab BiosimilarMarket Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bevacizumab Biosimilar
Figure Manufacturing Process Analysis of Bevacizumab Biosimilar
Figure Bevacizumab Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2016
Table Major Buyers of Bevacizumab Biosimilar
Table Distributors/Traders List
Figure Global Bevacizumab Biosimilar Sales and Growth Rate Forecast (2017-2022)
Figure Global Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Table Global Bevacizumab Biosimilar Sales Forecast by Type (2017-2022)
Table Global Bevacizumab Biosimilar Sales Forecast by Application (2017-2022)